Cite

HARVARD Citation

    Guan, J. et al. (2023). Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer. MAbs. 15 (1), p. . [Online]. 
  
Back to record